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Abstract The study was conducted to evaluate the met-
abolic responses to a 24 h ultra-endurance race in male
runners. Paired venous and capillary blood samples from
14 athletes (mean age 43.0 ± 10.8 years, body weight
64.3 ± 7.2 kg, VO2max 57.8 ± 6.1 ml kg
-1 min
-1), taken
3 h before the run, after completing the marathon distance
(42.195 km), after 12 h, and at the ﬁnish of the race, were
analyzed for blood morphology, acid–base balance and
electrolytes, lipid proﬁle, interleukin-6 (IL-6), high-sensi-
tivity C-reactive protein (hsCRP), and serum enzyme
activities. Mean distance covered during the race was
168.5 ± 23.1 km (range 125.2–218.5 km). Prolonged
ultra-endurance exercise triggered immune and inﬂamma-
tory responses, as evidenced by a twofold increase in total
leukocyte count with neutrophils and monocytes as main
contributors, nearly 30-fold increase in serum IL-6 and
over 20-fold rise in hsCRP. A progressive exponential
increase in mean creatine kinase activity up to the level
70-fold higher than the respective pre-race value, a several
fold rise in serum activities of aspartate aminotransferase
and alanine aminotransferase, and a fairly stable serum
c-glutamyl transferase level, were indicative of muscle, but
not of liver damage. With duration of exercise, there was a
progressive development of hyperventilation-induced
hypocapnic alkalosis, and a marked alteration in substrate
utilization towards fat oxidation to maintain blood glu-
cose homeostasis. The results of this study may imply that
progressive decline in partial CO2 pressure (hypocapnia)
that develops during prolonged exercise may contribute to
increased interleukin-6 production.
Keywords Ultra-endurance exercise  Muscle damage 
Inﬂammatory response  Interleukin-6
Introduction
As ultra-endurance events have become increasingly pop-
ular, many athletes compete in single day races lasting 4 up
to 24 h, or in multi-stage races performed over several
days. Competing in ultra-endurance events imposes a
severe metabolic stress and provokes acute cardio-respi-
ratory responses to ensure adequate oxygen supply to the
body. High level of physical demand during these events
induces a wide range of metabolic changes, causes micro-
injuries to the muscles and other tissues, which increases
migration of white blood cells to the sites of injury, and
induces acute phase inﬂammatory reactions (Kim et al.
2007; Tidball 2005; Bessa et al. 2008). Local response to
tissue injury involves the production of a large number of
acute phase proteins and cytokines. Among the latter, the
muscle-derived interleukin-6 is considered important
modulator of the immunological and metabolic responses
to exercise (Fischer 2006; Pedersen and Febbraio 2008).
Most studies on the metabolic responses to prolonged
endurance effort have evaluated changes taking place
immediately post-exercise and during the recovery period
(Wu et al. 2004; Suzuki et al. 2003, 2006; Castell et al.
1997; Kratz et al. 2002), while only few reports focused on
changes induced during ultra-endurance events (Kim et al.
2007, 2009; Wallberg et al. 2011), and very little attention
has been devoted to arterial blood gas and [H
?]
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DOI 10.1007/s00421-011-2135-5homeostasis during endurance exercise performed under
competitive conditions in the ﬁeld (Hanson et al. 1982).
The aim of the present study was to evaluate complex
metabolic responses that develop during a competitive 24-h
ultra-marathon run in male amateur endurance-trained
runners. A special focus was put on the changes in serum
interleukin-6 and its role in modulating the acute metabolic
responses to prolonged, endurance exercise.
Methods
Participants
Fourteen male amateur runners (mean age 43.0 ± 10.8
years, body weight 64.3 ± 7.2 kg, height 171 ± 5 cm,
percent body fat 13.9 ± 3.8%, weekly covered distance
81 ± 43 km, training history 8 ± 9 years) registered for a
24-h ultra-marathon, who volunteered to provide blood
samples during the race, were enrolled for the study. Before
the start of the race, after assessment of body composition
by the bioimpedance method (InBody220, Biospace), the
runners completed a questionnaire on their medical and
training history, and signed their consent to participate in
the study after being informed about the experimental
procedures approved by the local ethics committee, in
accordance with the Declaration of Helsinki. The runners
competed on a 3,014 m long oval recreational walking trail
located outside the town. Environmental conditions at the
race start at 8 PM were 11C and 67% relative humidity
(RH), at 8 AM and 12 AM next day were 11C (71% RH)
and 15C (55% RH), respectively, and at the completion of
the race at 8:00 PM were 15C (55% RH). The runners were
allowed free access to food and liquids, but the actual food
intakes were not recorded, which is a limitation of this
study. Liquids consisted mainly of water, sport beverages,
soft drinks and broth, while food supplements included
sandwiches, cookies, bananas, and carbohydrate energy
bars. Some days after the race, all competitors reported to
the physical testing laboratory for an incremental running
test on a treadmill (LE 200, Jaeger) to assess anaerobic
threshold and peak oxygen uptake (VO2max) using a sta-
tionary breath-by-breath metabolic unit (MetaLyzer 3B-R2,
Cortex). Performance characteristics of the runners are
presented in Table 1.
Blood sampling and biochemical analyses
Samples of venous and ﬁngertip capillary blood simulta-
neously collected 3 h before the race, after completing the
marathon distance (42.195 km), after 12 h, and not later
than 10 min after the race, were immediately transported to
a clinical laboratory for biochemical analyses including
blood morphology, blood gases and electrolytes, lipid pro-
ﬁle,C-reactive protein(hsCRP),andselected serum enzyme
activities. Blood morphology was assessed in venous blood
samples (anti-coagulated with EDTA) on an Automated
Hematology Analyzer XS-1000i
TM (Sysmex), while mea-
surementsofbloodgases,electrolytes,lactateandglucosein
ﬁngertip capillary blood were performed on the GEM Pre-
mier 3000 with IQM (Instrumentation Laboratory). Serum
activities of creatine kinase (CK), aspartate aminotransfer-
ase (AST), alanine aminotransferase (ALT) and c-glutamyl
transferase (GGT), as well as serum concentrations of total
cholesterol (TC), HDL-cholesterol, LDL-cholesterol, and
triglycerides (TG) were measured using the clinical chem-
istry analyzer SYNCHRON CX 9 PRO (Beckman-Coulter).
The intra-assay coefﬁcients of variation (CV) for these
assays were 5.8, 6.70, 5.30, 5.60% and 3.50, 6.10, 4.50%,
respectively. hsCRP was assessed in serum by a turbidi-
metric immunoassay using a Dade-Behring (Marburg,
Germany) kit (intra assay CV 3.45%). Total serum con-
centration of interleukin-6 (IL-6) was determined using
quantitative Human High Sensitivity ELISA kit (Gen-Probe
Diaclone SAS, France) (sensitivity\0.81 pg/ml, intra assay
CV 4.4%). Serum free fatty acids (FFA), glycerol and b-
hydroxybutyratecontentswereassessedusingcommercially
available manual test kits NEFA, Glycerol (GLY) and
RANBUT (CV: 2.7, 1.34, 4.71%, respectively) from Ran-
dox Laboratories (Antrim, UK). To estimate the risk of
coronary artery disease (CAD) in the ultra-marathoners, we
calculated the lipid ratios (TC/HDL, LDL/HDL, TG/HDL)
and plasma atherogenic index [atherogenic index of plasma
(AIP) = log10(TG/HDL)] (Dobia ´s ˇova ´ and Frohlich 2001).
Statistics
Data are presented as the mean (SD). The data were tested
for homogeneity of variances by using the Levene test and
then analyzed either by the nonparametric Wilcoxon test or
by one-way repeated measures ANOVA followed, where
Table 1 Performance characteristics of the runners (N = 14)
Variable Mean ± SD Min–Max
VO2max (mL O2/kg/min) 57.8 ± 6.1 49.0–71.0
VO2max (mL O2/kg
0.75/min) 164.7 ± 15.5 140.3–195.5
Individual anaerobic threshold
(mL O2/kg/min)
48.9 ± 5.1 39.0–57.0
Lactate threshold (%VO2max) 84.2 ± 4.0 77–92
Velocity at lactate threshold
(km/h)
13.1 ± 0.9 12–14
VEmax (L/min) 140.1 ± 19.4 117.0–193.4
Peak heart rate HRmax (bpm) 182.1 ± 10.0 165–198
Peak lactate concentration
(mmol/L)
8.64 ± 1.91 5.90–11.64
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123appropriate, by the Tukey post-hoc test. Spearman’s rank
order correlation analysis was used to assess relationships
between selected variables. The level of signiﬁcance of
P\0.05 was chosen for all statistical comparisons.
Results
Ultra-marathon performance and physiological proﬁle
of the competitors
The running performance data of the competitors are
presented in Table 2. The highest running velocity was
attained at the ﬁrst stage of the race, i.e. over the mara-
thon (42.195 km) distance, then it decreased markedly to
reach a signiﬁcantly lower level both over the mid-race
and over the whole distance covered. There were marked
differences in individual race performance measures;
however, running velocity was not signiﬁcantly related to
age, body mass, BMI, or lean body mass (LBM). Note-
worthy, running velocity appeared to be positively corre-
lated with individual anaerobic threshold IAT (R = 0.40,
P\0.01), VO2max (R = 0.33, P\0.05) and with peak
oxygen uptake expressed in relation to (body mass)
0.75
(R = 0.38, P\0.05), which is considered a more reliable
measure of oxygen uptake when comparing individuals
with different body mass (Bergh et al. 1991). The mean
values of VO2max recorded in our younger (\40 years,
N = 6) and older ([40 years, N = 8) runners during a
progressive treadmill running test, which equaled
59.8 ± 6.7 and 56.3 ± 5.4 mlO2/kg/min, respectively,
were comparable to those reported by Wilmore and Costill
(2005) for younger (18–39 years) or older (40–60 years)
endurance-trained runners (60–85 and 40–60 ml/kg/min,
respectively). The importance of a high VO2max for per-
formance in ultra-marathon events (Kreider 1991; Joyner
and Coyle 2008; Millet et al. 2011) was additionally
supported by our ﬁnding of signiﬁcant correlations
between VO2max or IAT and running velocity (see above)
or distance covered during the race (R = 0.57, P\0.05
or R = 0.74, P\0.005, respectively), which proves that
the higher is VO2max and anaerobic threshold, the easier is
to run at a given submaximal velocity in long-distance
events (Noakes et al. 1990). Although a high VO2max
would contribute greatly to performance in endurance
events at the highest level, other markers such as lactate
threshold (LT) and running velocity at lactate threshold
(vLT) are considered to be more predictive. The mean
values for IAT, lactate threshold expressed as %VO2max
and vLT tended to be higher in younger compared to older
runners (51 vs. 45 ml/kg/min; 85 vs. 80%, and 13.5 vs.
12.0 km/h, respectively), but in all cases they were com-
parable to those achieved by well-trained athletes (Wil-
more and Costill 2005). Notably, compared to the mean
running velocity at the anaerobic threshold (13.1 ± 0.9
km/h), which has been assessed during graded treadmill
running test, expressed as a percent of maximal oxygen
uptake equal, on average, 84.2 ± 4.0 %VO2max (Table 1),
the average speed sustained over the ﬁrst 12 h or the
whole 24 h race, corresponded to 51 or 40% VO2max,
which is comparable to that (40% VO2max) found by
Millet et al. (2011).
Biochemical data
Capillary blood gases and acid–base balance indices were
within the normal ranges at rest, but they changed signif-
icantly with the progress of the race. A progressive respi-
ratory alkalosis contributed to a mean increase in pH of
0.067 units from rest to the end of the competition, coin-
cident with signiﬁcant hypocapnia resulting from a 23%
decrease in pCO2 (Table 3). This was accompanied by a
progressive increases in pO2 of about 11 mmHg, oxygen
saturation and plasma potassium, and a tendency towards
lower free (ionized) calcium, while plasma sodium con-
centration remained unchanged (Table 3). It should be
stressed that capillary blood gases accurately predict arte-
rial carbon dioxide pressure, and arterial plasma lactate,
glucose, pH, hemoglobin and electrolytes, but not arterial
oxyhemoglobin saturation and arterial oxygen pressure
(Zavorsky et al. 2005). Running the marathon distance led
to a marked leukocytosis with signiﬁcant increases in
absolute neutrophil and monocyte counts and decreases in
eosinophil count (Table 4). In contrast, no signiﬁcant
changes in any of the basic blood counts from baseline
levels were found during the whole competition (Table 4).
Dramatic increases over the baseline values in muscle
damage and inﬂammatory markers were observed
(Table 5). Notably, serum activity of CK increased by 70
times, of AST—by 14 times, of ALT—by 4 times, while
Table 2 Ultra-marathon (24 h) race performance measures
Variable Mean ± SD Median Min–Max
Marathon time (h) 4.6 ± 0.4 4.7 4.1–5.3
Marathon running
velocity (km/h)
9.1 ± 0.7 9.0 8.0–10.2
12-h distance ( km) 94.6 ± 11.6 94.0 73.0–109.0
12-h running velocity
( km/h)
7.9 ± 1.0* 7.83 6.1–9.1
24-h distance ( km) 168.5 ± 23.1 165.9 125.2–218.5
24-h running velocity
(km/h)
7.0 ± 1.0* 6.9 5.2–9.1
* Signiﬁcantly different (P\0.05) from the running velocity
achieved at the marathon distance
Eur J Appl Physiol (2012) 112:1679–1688 1681
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123hsCRP level was over 20-fold and IL-6 concentration—30-
fold higher at the ﬁnish than at the start of the race. In
contrast, serum GGT activity and blood concentrations of
lactate and glucose remained fairly stable (Table 5).
The ultra-endurance race was also associated with
marked changes in circulating levels of FFA, b-hydroxy-
butyrate, glycerol, and TG (Table 6). This was accompa-
nied by signiﬁcant declines in serum total and LDL
cholesterol levels and a signiﬁcant increase in serum HDL
cholesterol. Lipid ratios (LDL/HDL, TC/HDL, and TG/
HDL), as well as AIP were signiﬁcantly reduced post-race.
In order to assess the impact of the ultra-endurance race on
selected biochemical parameters, and on muscle damage
and inﬂammatory markers, the Spearman rank correlation
coefﬁcients were calculated; selected statistically signiﬁ-
cant associations are shown in Table 7.
Discussion
The present investigation used 24 h foot race to study
metabolic responses during prolonged submaximal exer-
cise. The current study conﬁrmed previous ﬁndings that
continuous, prolonged, moderate-intensity running exer-
cise is associated with severe muscle damage, markedly
elevated IL-6 and hsCRP concentrations, and favorable
changes in serum lipid proﬁle. The results of this study
may imply that hyperventilation-induced respiratory alka-
losis with a progressive hypocapnia might contribute, at
least to some extent, to increased IL-6 cytokine production.
Metabolic responses to the 24 h race
The extreme caloric demand during ultra-endurance com-
petition requires an adequate supply of metabolic fuels
(Kreider 1991; Zaryski et al. 2005). Because carbohydrate
stores in the body are limited, the long-duration muscle
activity raises the need for carbohydrates not only as an
energy source for muscles, but also for their role both in
the rapid metabolizing of fats for energy and in providing
glucose for normal functioning of the central nervous.
Therefore, the adequate supply of carbohydrates is con-
sidered crucial for endurance athletes. Since the runners in
the present study had free access to food during the entire
event, no signiﬁcant changes in blood glucose concentra-
tion were found, which implies adequate carbohydrate
supply during the competition. On the other hand, it could
be easily predicted that the ultra-endurance race will have a
major impact on fat metabolism, and in particular will
enhance fat oxidation (Helge et al. 2007; Jeukendrup et al.
1998). Since the athletes were not fed with large amount
of lipids, our ﬁndings of a more than 50% decrease in
serum triacylglycerols, associated with signiﬁcant, almost
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123threefold increases in circulating FFA, glycerol and
b-hydroxybutyrate, reﬂect the use of fatty acids as fuels.
These results support the view that marathon runners
compared with normal individuals have a higher fat turn-
over rate at submaximal exercise intensities (Sjo ¨din and
Svedenhag 1985). It is worth to note that the decrease in
TG was associated with signiﬁcant decline in total and
LDL cholesterol and a signiﬁcant rise in HDL cholesterol.
Moreover, highly signiﬁcant negative correlations between
the distance covered during the race and several lipid
proﬁle indices (serum TG, cholesterol total, LDL and
HDL) strongly support the view of the beneﬁcial effect of
endurance effort on serum lipid proﬁle. It should be
stressed that not only concentrations of TG, total choles-
terol and its fractions as the independent risk factors, but
also the common cholesterol ratios (TC/HDL, LDL/HDL,
and TG/HDL), which are considered better predictors of
future coronary heart disease (Natarajan et al. 2003;
Kinosian et al. 1994; Grover et al. 1999) were already
relatively low at the start of the race, and reached the
lowest levels at the ﬁnish. As expected, total and
LDL-cholesterol were signiﬁcantly positively related with
age in the participating runners. Comparable changes in
the lipid proﬁle after prolonged exercise, suggesting
reduction in cardiovascular disease (CVD) risk, were
also observed by other authors (Gastmann et al. 1998;
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Table 7 Spearman rank correlation coefﬁcients between the distance
covered during the 24 h ultra marathon race and selected hemato-
logical and biochemical indices
Variables RP
Distance and pH 0.69 \10
-6
Distance and pCO2 –0.75 \10
-6
Distance and ionized Ca –0.41 \0.005
Distance and K
? 0.80 \10
-6
Distance and total WBC count 0.56 \10
-5
Distance and neutrophil absolute count 0.60 \10
-6
Distance and monocyte absolute count 0.74 \10
-6
Distance and eosinophil absolute count –0.64 \10
-6
Distance and hsCRP 0.82 \10
-6
Distance and IL-6 0.68 \10
-5
Distance and CK 0.87 \10
-6
Distance and AST 0.82 \10
-6
Distance and ALT 0.81 \10
-6
Distance and total cholesterol –0.42 \0.05
Distance and LDL-Cholesterol –0.46 \0.05
Distance and HDL-Cholesterol 0.70 \10
-4
Distance and TG –0.56 \0.005
Distance and FFA 0.50 \0.0005
Distance and b-hydroxybutyrate 0.46 \0.001
Distance and AIP [log10(TG/HDL)] –0.66 \0.0005
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123Ginsburg et al. 1996). We are aware that there are more
accurate methods to estimate the risk of CVD and ath-
erosclerosis, e.g. determining lipoprotein(a) level or par-
ticle size distribution in LDL (Superko 1996). However, a
surrogate method for evaluation of the atherogenicity of
plasma lipoproteins based on the assessment of the AIP
calculated as log(TG/HDL-C) (with TG and HDL-C
expressed in molar concentrations) may also be useful
(Dobia ´s ˇova ´ and Frohlich 2001). The most recent ﬁndings
from studies in a cohort of adult subjects on the negative
correlation between AIP and particle sizes of HDL and
LDL support the view that AIP is a reliable predictor of
the cardiovascular risk (Dobia ´s ˇova ´ et al. 2011). It should
be stressed, therefore, that negative AIP values, which
have been found in a half of the runners at the start of the
race and in all of them—at the ﬁnish, may indicate a
lowered risk of CVD. Taking into account that changes in
concentration of small dense LDLs are signiﬁcantly cor-
related with changes in TG (Baumstark et al. 1993), it
may be postulated that the reduction in pro-atherogenic
small dense LDLs induced by prolonged endurance effort
would be larger in subjects with larger reductions in
serum TG.
Another important aspect of metabolic response to
ultra-endurance efforts is the role of IL-6. The concen-
tration of this cytokine correlated positively with serum
FFA (R = 0.47, P\0.005), glycerol (R = 0.42, P\
0.005) and HDL-C (R = 0.63, P\0.005) levels, and
negatively—with serum TG (R =- 0.46, P\0.05).
These ﬁndings strongly support the view that IL-6
enhances lipid turnover by stimulating lipolysis and fat
oxidation (Bruce and Dyck 2004; Petersen and Pedersen
2005), thus it may be considered as one possible mediator
of the beneﬁcial effects of physical activity on fatty acid
metabolism. Data from the literature provide also a strong
evidence that IL-6 is involved in mediating glucose
homeostasis during exercise (Petersen and Pedersen
2005), notably that activation of the IL-6 gene during
exercise may be sensitive to muscle glycogen content.
Low muscle glycogen substantially enhances IL-6 gene
transcription and IL-6 protein production in skeletal
muscles, whereas carbohydrate ingestion during exercise
attenuates increases in plasma IL-6 (Keller et al. 2001;L i
and Gleeson 2005). With regard to the results of the
present study, one should notice that free access to car-
bohydrate-rich food during the race did not preclude the
possibility that muscle glycogen stores in our runners
were depleted, which could activate IL-6 expression.
Sustained supply of exogenous sugars allowed the com-
petitors to complete the race with no impairment of glu-
cose homeostasis, although well maintained glucose
concentration could blunt the response of serum IL-6 (Li
and Gleeson 2005).
Ventilatory and immune responses to ultra-endurance
exercise
It is well known that a continuous long-lasting run elicits a
ventilatory response. The most distinctive feature of the
response is a tachypnea associated with variable degrees of
hypocapnia and respiratory alkalosis (Hanson et al. 1982).
The hypocapnia develops when a strong respiratory stim-
ulus causes the lungs to remove more carbon dioxide than
is produced in metabolically active tissues. Indeed, in the
present study a variable degree of hypocapnia and respi-
ratory alkalosis did develop during the race. Alkalosis at
the completion of the race was evident in nine subjects,
showing above-normal pH values (7.46–7.51) and pCO2
less than 35 mmHg. This was associated with a tendency
towards a lowered free ionized calcium concentration.
Hyperventilation-induced decreases in plasma concentra-
tions of CO2,[ H
?] and available calcium, acting as potent
vasodilators during exercise, may limit O2 delivery to
locomotor skeletal muscle by causing vascular constriction
and reducing blood ﬂow (Chin et al. 2007). Of note, we
have found in this study that serum IL-6 level correlated
negatively with capillary blood pCO2 (R =- 0.51,
P\0.001), while it correlated positively with capillary
blood pH (R = 0.53, P\0.0005). These ﬁndings may
imply that the respiratory-induced hypocapnic alkalosis
might, at least to some extent, modulate in vivo production
of this cytokine. To our knowledge, there is but a single
study providing evidence that CO2 concentrations modu-
lated cytokine levels in endotoxin-stimulated human whole
blood cell cultures (Kimura et al. 2008). Notably, those
authors found that hypocapnic alkalosis stimulated IL-6
production, whereas the opposite effect, i.e. a reduced IL-6
concentration was observed after hypercapnic acidosis.
Given that no detectable amounts of this cytokine were
found by those authors in blood samples without endotoxin
stimulation, one may presume that the elevated serum IL-6
evidenced during and after the 24 h race in all athletes in
our study was, at least partly, due to exercise-induced
muscle damage (Suzuki et al. 2006; Nieman 1997) and/or
ensuing endotoxemia resulting from increased intestinal
permeability (Jeukendrup et al. 2000). This presumption
is strongly supported by positive correlations between
serum IL-6 level and serum activities of CK (R = 0.65,
P\10
-4), AST (R = 0.77, P\10
-4) and ALT (R =
0.79, P\10
-4) that are considered indirect markers of
work-induced muscle damage. Abnormally high serum
activities of these enzymes are indicative of their leakage
from skeletal muscle or other tissues into the bloodstream
due to mechanical damage or increased membrane
permeability.
Recent research demonstrated that plasma IL-6 increa-
ses exponentially with exercise intensity and duration, and
Eur J Appl Physiol (2012) 112:1679–1688 1685
123the mass of muscle recruited (Pedersen and Febbraio 2005,
2008). However, a fairly stable serum IL-6 concentration
evidenced in the present study, as well as a signiﬁcant
correlation between IL-6 and distance covered (R = 0.68,
P\10
-5), seem to support most recent ﬁnding of Wall-
berg et al. (2011) that IL-6 does not increase after 12 h of
exercise, which suggests that the main determinant of the
IL-6 response is the intensity of exercise.
The results of our study demonstrate that running a
24 h ultra-marathon resulted in highly signiﬁcant increases
in serum activities of CK, AST and ALT, emerging in the
second half of the race (between 12 and 24 h). Substantial
increases in serum activities of AST and ALT following
prolonged exercise, and fairly stable serum GGT are
indicative of signiﬁcant skeletal muscle and minor hepatic
damage (Noakes 1987;Whitﬁeld 2001; Rosales et al.
2008). In our study, the highest increase was recorded
(Table 5) for the mean serum activity of CK that is widely
accepted as an indirect marker of muscle damage (Noakes
et al. 1983; Kim et al. 2007, 2009; Miles et al. 2008;
Brancaccio et al. 2010). However, there were remarkable
inter-individual differences in the relative magnitude of
the increase, amounting to 27-fold difference between the
highest and the lowest response. The reason for this var-
iability is not clear; however, one may suspect that the
extreme increases in serum CK activity may be related to
the development of exertional rhabdomyolysis (Skenderi
et al. 2006).
The body’s response to tissue damage involves mobili-
zation of immune cells and their migration towards sites of
the injury (Tidball 2005; Kim et al. 2007; Bessa et al. 2008;
Nieman 1997). In the present study, the immune response
to muscle damage was characterized by a pronounced,
almost twofold increase in total WBC count at the com-
pletion of the marathon distance, which persisted until the
end of the race. The major components were neutrophils
and monocytes, which reached counts almost three times
those pre-race. It is known that increases in leukocyte
counts during sustained moderate exercise, even in ther-
mally comfortable environment (which was the case in the
present study), are related mainly to elevations in plasma
catecholamines, which induce a demargination of leuko-
cytes (Brenner et al. 1998). It is well established that the
release of leukocytes, and particularly neutrophils and
monocytes, is stimulated by inﬂammatory mediators, such
as IL-6 (Suzuki et al. 2003; Nieman 1997). This assump-
tion is corroborated by our ﬁnding that IL-6 responses
correlated signiﬁcantly with ultra-endurance exercise-
induced increases in total leukocyte (R = 0.56, P\10
-4),
absolute neutrophil (R = 0.57, P\10
-4) and monocyte
(R = 0.71, P\10
-7) counts, which seems to support the
previous ﬁndings that IL-6 may mediate recruitment and
activation of neutrophils and monocytes in response to
exhaustive exercise (Suzuki et al. 2003). However, it is
well documented that IL-6 is produced in skeletal muscles
also in non-inﬂammatory conditions, and that muscle
contraction per se is a major stimulus for de novo synthesis
of IL-6 in myocytes (Hiscock et al. 2004; Pedersen and
Febbraio 2008).
One important feature of IL-6 is that it induces the
production of hepatocyte-derived CRP (Fischer 2006) that
is involved in the induction of anti-inﬂammatory cytokines
in circulating monocytes, in suppression of the synthesis of
proinﬂammatory cytokines in tissue macrophages (Pue
et al. 1996) and is responsible for the recognition and
removal of damaged cells (Plaisance and Grandjean 2006).
In our study, plasma hsCRP concentration during the ﬁrst
42.195 km distance was fairly stable. Changes in plasma
hsCRP content occurred later, i.e. after ﬁnishing the mar-
athon distance, when it rose in an exponential pattern to
reach, at the ﬁnish of a 24 h race, the level more than 20
times higher than the pre-race value. Signiﬁcant correlation
between plasma CRP and IL-6 found in our study
(R = 0.51, P\0.0005) supports the presumption of the
role of IL-6 as a primary inducer of hepatic production of
acute phase proteins (Fischer 2006).
In summary, the main metabolic responses to the 24-h
ultra-marathon race were: (i) a marked shift in substrate
utilization towards fat oxidation to maintain blood glucose
homeostasis, and (ii) favorable changes in serum lipid
proﬁle. The ultra-endurance run led to a substantial skel-
etal muscle damage and an acute inﬂammatory response
evidenced by a wide range of changes in muscle injury-
related indices and dramatic elevations in serum interleu-
kin-6 and hsCRP. These effects were more pronounced
during the second half of the race, and the primary
determinants of these changes were both the duration and
intensity of the exercise. The predominant ventilatory
response to the ultra-endurance effort of the 24 h race was
a tachypneic, respiratory alkalosis associated with hypo-
capnia and hyperkalemia, but not hyponatremia. Some
results of this study suggest that the elevation in serum
IL-6, which likely is due to increased production, might be
related to hypocapnia that develops during prolonged
endurance exercise. However, the correlation between
these phenomena may as well be an indirect, non-causal
association related to the effects of prolonged muscle
effort on both pCO2 and IL-6.
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